Evidence map›Paper›PMID 36292215›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients.

Kathleen Schüler, Daniel Bethmann, Sandy Kaufhold, Carolin Hartung, Kathrin Stückrath, Tilmann Lantzsch, Christoph Uleer, Volker Hanf, Susanne Peschel, Jutta John and 7 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Prognostic significance of ductal carcinomaMolecular and clinical oncology · 2026
    Article
  2. Observational
  3. Article
  4. Targeting low-risk triple-negative breast cancer: a review on de-escalation strategies for a new era.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kathleen SchülerDepartment of Gynaecology, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Daniel BethmannInstitute of Pathology, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.ORCID 0000-0002-9582-025X
Sandy KaufholdDepartment of Gynaecology, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Carolin HartungDepartment of Gynaecology, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Kathrin StückrathDepartment of Gynaecology, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Tilmann LantzschDepartment of Gynaecology, Hospital St. Elisabeth and St. Barbara, 06110 Halle (Saale), Germany.
Christoph UleerGynäkologisch-Onkologische Praxis, 31134 Hildesheim, Germany.
Volker HanfDepartment of Gynaecology, Nathanstift, Hospital Fürth, 90766 Fürth, Germany.
Susanne PeschelDepartment of Gynaecology, St. Bernward Hospital, 31134 Hildesheim, Germany.
Jutta JohnDepartment of Gynaecology, Helios Hospital Hildesheim, 31135 Hildesheim, Germany.
Marleen PöhlerDepartment of Gynaecology, Asklepios Hospital Goslar, 38642 Goslar, Germany.
Jörg BuchmannInstitute of Pathology, Hospital Martha-Maria, 81479 Halle (Saale), Germany.
Karl-Friedrich BürrigInstitute of Pathology Hildesheim, 31135 Hildesheim, Germany.
Edith WeigertInstitute of Pathology, Hospital Fürth, 90766 Fürth, Germany.
Christoph ThomssenDepartment of Gynaecology, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Eva Johanna KantelhardtDepartment of Gynaecology, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Martina VetterDepartment of Gynaecology, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.

Funding

German Federal Ministry of Education and Research e:Med FKZ: 031A429Martin Luther University Halle Wittenberg FKZ 25/36
6 · The paper itself

Abstract

Tumour-infiltrating lymphocytes (TILs) are considered to have prognostic and predictive value for patients with early breast cancer. We examined 1166 breast cancer patients from a prospective, multicentre cohort (Prognostic Assessment in Routine Application (PiA),

Indexed as

cohort studyearly breast cancerprognosistumor infiltrating lymphocytes

Identifiers

PMID36292215
PMCPMC9601161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.